Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
The Journal of Biological Chemistry
|
October 5, 1989
Estrogen regulation of tissue-specific expression of complement C3
S A Sundstrom, B S Komm, H Ponce-de-Leon, et al.
Journal of the National Cancer Institute
|
August 1, 1981
Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas
J A Holt, C R Lyttle, M A Lorincz, et al.
Clinical Orthopaedics and Related Research
|
July 1, 1992
Estrogen receptors in fracture healing
B A Monaghan, F S Kaplan, C R Lyttle, et al.
DNA (Mary Ann Liebert, Inc.)
|
June 1, 1988
Regulation of alpha 2(I), alpha 1(III), and alpha 2(V) collagen mRNAs by estradiol in the immature rat uterus
F R Frankel, C Y Hsu, J C Myers, et al.
Endocrinology
|
February 2, 1999
Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses
R J Roper, J S Griffith, C R Lyttle, et al.
The American Journal of Pathology
|
June 1, 1997
Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes
J S Griffith, S M Jensen, J K Lunceford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats
L M Greenberger, T Annable, K I Collins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1987
Endometrial cytosolic and nuclear progesterone receptors in the luteal phase defect
M H Jacobs, J Balasch, J M Gonźalez-Merlo, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
The Journal of Biological Chemistry
|
October 5, 1989
Estrogen regulation of tissue-specific expression of complement C3
S A Sundstrom, B S Komm, H Ponce-de-Leon, et al.
Journal of the National Cancer Institute
|
August 1, 1981
Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas
J A Holt, C R Lyttle, M A Lorincz, et al.
Clinical Orthopaedics and Related Research
|
July 1, 1992
Estrogen receptors in fracture healing
B A Monaghan, F S Kaplan, C R Lyttle, et al.
DNA (Mary Ann Liebert, Inc.)
|
June 1, 1988
Regulation of alpha 2(I), alpha 1(III), and alpha 2(V) collagen mRNAs by estradiol in the immature rat uterus
F R Frankel, C Y Hsu, J C Myers, et al.
Endocrinology
|
February 2, 1999
Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses
R J Roper, J S Griffith, C R Lyttle, et al.
The American Journal of Pathology
|
June 1, 1997
Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes
J S Griffith, S M Jensen, J K Lunceford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats
L M Greenberger, T Annable, K I Collins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1987
Endometrial cytosolic and nuclear progesterone receptors in the luteal phase defect
M H Jacobs, J Balasch, J M Gonźalez-Merlo, et al.
Page
of 7